(ADNT) Adient - Overview
Sector: Consumer Cyclical | Industry: Auto Parts | Exchange: NYSE (USA) | Market Cap: 1.542m USD | Total Return: 39.2% in 12m
Avg Turnover: 18.2M
Qual. Beats: 0
Rev. Trend: -72.5%
Qual. Beats: 2
Warnings
Altman Z'' -0.10 < 1.0 - financial distress zone
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Adient plc is a global leader in the automotive seating industry, specializing in the design and manufacture of complete seating systems and individual components such as frames, foams, and trim covers. The company operates as a Tier 1 supplier, selling directly to original equipment manufacturers (OEMs) across major markets in the Americas, Europe, and Asia.
The automotive parts sector is characterized by high capital intensity and complex supply chain integration, where suppliers often co-locate facilities near OEM assembly plants to minimize logistics costs. Adient’s business model relies on long-term platform contracts that typically span the multi-year lifecycle of a specific vehicle model. For a deeper look into the companys financial health, consider reviewing the fundamental metrics on ValueRay.
Incorporated in 2016 and headquartered in Dublin, Ireland, Adient supports a broad range of vehicle categories, including passenger cars, commercial vehicles, and light trucks. Its global footprint allows it to capture regional demand shifts and maintain diverse revenue streams across the international automotive landscape.
- Global automotive production volumes dictate demand for complete seating systems
- Raw material price volatility impacts margins for frames and foam components
- Market share growth in China remains critical for long-term revenue expansion
- Labor cost inflation and supply chain disruptions pressure operational profitability
- Shift toward electric vehicle platforms drives new seating architecture design wins
| Net Income: 59.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 2.52% < 20% (prev 2.66%; Δ -0.14% < -1%) |
| CFO/TA 0.06 > 3% & CFO 552.0m > Net Income 59.0m |
| Net Debt (1.56b) to EBITDA (759.0m): 2.05 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.3m) vs 12m ago -5.60% < -2% |
| Gross Margin: 6.34% > 18% (prev 0.06%; Δ 627.5% > 0.5%) |
| Asset Turnover: 169.5% > 50% (prev 167.5%; Δ 2.08% > 0%) |
| Interest Coverage Ratio: 1.95 > 6 (EBITDA TTM 759.0m / Interest Expense TTM 222.0m) |
| A: 0.04 (Total Current Assets 4.25b - Total Current Liabilities 3.87b) / Total Assets 9.03b |
| B: -0.13 (Retained Earnings -1.16b / Total Assets 9.03b) |
| C: 0.05 (EBIT TTM 433.0m / Avg Total Assets 8.81b) |
| D: -0.27 (Book Value of Equity -1.87b / Total Liabilities 6.94b) |
| Altman-Z'' = -0.10 = B |
| DSRI: 1.04 (Receivables 2.03b/1.89b, Revenue 14.9b/14.4b) |
| GMI: 1.02 (GM 6.34% / 6.46%) |
| AQI: 0.96 (AQ_t 0.38 / AQ_t-1 0.39) |
| SGI: 1.04 (Revenue 14.9b / 14.4b) |
| TATA: -0.05 (NI 59.0m - CFO 552.0m) / TA 9.03b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 21.58 with a total of 314,758 shares traded.
Over the past week, the price has changed by +3.55%,
over one month by -2.53%,
over three months by -13.30% and
over the past year by +39.23%.
Adient has received a consensus analysts rating of 3.08. Therefore, it is recommended to hold ADNT.
- StrongBuy: 2
- Buy: 0
- Hold: 8
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 31.4 | 45.6% |
P/E Trailing = 30.2615
P/E Forward = 8.8574
P/S = 0.1033
P/B = 0.9004
P/EG = 0.1362
Revenue TTM = 14.9b USD
EBIT TTM = 433.0m USD
EBITDA TTM = 759.0m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 9.00m USD (from shortTermDebt, last quarter)
Debt = 2.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.56b USD (calculated: Debt 2.39b - CCE 831.0m)
Enterprise Value = 3.10b USD (1.54b + Debt 2.39b - CCE 831.0m)
Interest Coverage Ratio = 1.95 (Ebit TTM 433.0m / Interest Expense TTM 222.0m)
EV/FCF = 11.15x (Enterprise Value 3.10b / FCF TTM 278.0m)
FCF Yield = 8.97% (FCF TTM 278.0m / Enterprise Value 3.10b)
FCF Margin = 1.86% (FCF TTM 278.0m / Revenue TTM 14.9b)
Net Margin = 0.39% (Net Income TTM 59.0m / Revenue TTM 14.9b)
Gross Margin = 6.34% ((Revenue TTM 14.9b - Cost of Revenue TTM 14.0b) / Revenue TTM)
Gross Margin QoQ = 6.36% (prev 5.95%)
Tobins Q-Ratio = 0.34 (Enterprise Value 3.10b / Total Assets 9.03b)
Interest Expense / Debt = 9.30% (Interest Expense 222.0m / Debt 2.39b)
Taxrate = 42.11% (32.0m / 76.0m)
NOPAT = 250.7m (EBIT 433.0m * (1 - 42.11%))
Current Ratio = 1.10 (Total Current Assets 4.25b / Total Current Liabilities 3.87b)
Debt / Equity = 1.39 (Debt 2.39b / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 2.05 (Net Debt 1.56b / EBITDA 759.0m)
Debt / FCF = 5.60 (Net Debt 1.56b / FCF TTM 278.0m)
Total Stockholder Equity = 1.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.67% (Net Income 59.0m / Total Assets 9.03b)
RoE = 2.03% (Net Income TTM 59.0m / Total Stockholder Equity 2.91b)
RoCE = 8.19% (EBIT 433.0m / Capital Employed (Equity 2.91b + L.T.Debt 2.38b))
RoIC = 4.87% (NOPAT 250.7m / Invested Capital 5.15b)
WACC = 8.04% (E(1.54b)/V(3.93b) * Re(12.16%) + D(2.39b)/V(3.93b) * Rd(9.30%) * (1-Tc(0.42)))
Discount Rate = 12.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -7.10%
[DCF] Terminal Value 77.97% ; FCFF base≈260.8m ; Y1≈299.0m ; Y5≈440.0m
[DCF] Fair Price = 64.58 (EV 6.62b - Net Debt 1.56b = Equity 5.06b / Shares 78.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.05 | # QB: 0
Revenue Correlation: -72.55 | Revenue CAGR: -2.02% | SUE: 2.40 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.56 | Chg30d=-8.92% | Revisions=-7% | Analysts=12
EPS current Year (2026-09-30): EPS=2.13 | Chg30d=+1.84% | Revisions=+12% | GrowthEPS=+10.4% | GrowthRev=+2.2%
EPS next Year (2027-09-30): EPS=3.35 | Chg30d=+4.88% | Revisions=+60% | GrowthEPS=+57.1% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +60%